Advanced Cell Therapeutics Secures Exclusive License to Second Anti-Cancer Therapeutic from the University of Louisville's Brown Cancer Center

Published: Mar 25, 2008

LOUISVILLE, Ky.--(BUSINESS WIRE)--Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has signed an exclusive license to develop and market 4-IPP and its related compounds, discovered by scientists at the University of Louisvilleā€™s James Graham Brown Cancer Center (Brown Cancer Center).

Back to news